Br Med J (Clin Res Ed)  1986;293:988-992 (18 October), doi:10.1136/bmj.293.6553.988

Course of blood pressure in mild hypertensives after withdrawal of long term antihypertensive treatment. Medical Research Council Working Party on Mild Hypertension.

A series of 1418 men and 1,347 women with mild hypertension (diastolic phase V 90-109 mm Hg) aged 35-64 who had either had long term antihypertensive treatment with bendrofluazide or propranolol or taken placebo tablets for a similar period were randomly allocated to groups in which their tablets were either stopped or continued. The course of blood pressure and of biochemical variables was followed up for two years. Mean blood pressures rose rapidly after the withdrawal of active treatment, and between nine months and one year after stopping treatment the antihypertensive effect had almost disappeared. The effect persisting longer than this, and possibly due to resetting of the baroreceptors or of other blood pressure control mechanisms, was very small, and as the rise in mean pressure was due to an upward movement in general distribution there was no evidence of a subgroup in whom these mechanisms had been permanently reset to a clinically important extent. After withdrawal of propranolol the rise in pressure was more rapid in younger than in older people. After stopping bendrofluazide pressure rose more rapidly in men who had had higher pressures before and during treatment; this effect was not seen in women. Disturbances in biochemical variables associated with drug treatment had largely resolved by the end of two years after withdrawal. Stopping placebo tablets made no consistent difference to blood pressure.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Julius, S., Nesbitt, S., Egan, B., Kaciroti, N., Schork, M. A., Grozinski, M., Michelson, E., for the TROPHY study group, (2004). Trial of Preventing Hypertension: Design and 2-Year Progress Report. Hypertension 44: 146-151 [Abstract] [Full text]  
  • Takata, Y., Yoshizumi, T., Ito, Y., Hirota, Y., Fujishima, M. (1995). Effect of Administration and Withdrawal of Doxazosin on Ambulatory Blood Pressure in Patients with Essential Hypertension. ANGIOLOGY 46: 11-18 [Abstract]  
  • Takata, Y., Yoshizumi, T., Ito, Y., Hirota, Y., Fujishima, M. (1994). Doxazosin Withdrawal and Ambulatory Blood Pressure Monitoring in Normotensive Subjects. ANGIOLOGY 45: 17-23 [Abstract]  
  • Zell, S. C., Lardinois, C. K. (1993). Treatment of Mild Hypertension: Decision Before Drugs. Arch Fam Med 2: 778-786 [Abstract]  
  • (1993). National High Blood Pressure Education Program Working Group Report on Primary Prevention of Hypertension. Arch Intern Med 153: 186-208 [Abstract]  
  • Schmieder, R. E., Rockstroh, J. K., Messerli, F. H. (1991). Antihypertensive Therapy: To Stop or Not to Stop?. JAMA 265: 1566-1571 [Abstract]  
Access jobs at BMJ Careers
Whats new online at Student BMJ